Taloxa, Suspension zum Einnehmen

7680526790284 CH-52679 suspension

Associated product:

TALOXA susp 600mg/5ml 230 ml
Taloxa, Suspension zum Einnehmen
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
230
Selling units
230
Measure
ml
Galenic form
suspension
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
felbamatum
600.0 MG Substance Wirkstoff (Principe actif)
cellulosum microcristallinum et carmellosum natricum
- Substance HNIDK
sorbitolum liquidum cristallisabile
1.5 G Substance HBESI
glycerolum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
simeticoni emulsio
- Substance HNIDK
aromatica
- Substance AROMA
ethanolum
1.08 MG Substance HBESI
saccharinum natricum
- Substance HNIDK
natrii benzoas
10.0 MG Substance HBESI
propylis parahydroxybenzoas
1.0 MG Substance HBESI
E 218
6.5 MG Substance HBESI
aqua purificata
- Substance HNIDK
natrium
2.804 MG Substance HBESI

Reimbursement information

Public price
CHF 118.95
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1998

Authorization holder

Organon GmbH

6006 Luzern

Authorization information

Swissmedic authorization number
52679
Drug name
Taloxa, Suspension zum Einnehmen
Galenic form
SUOR
ATC Code
N03AX10
Authorization status
Z
Dispensing category
A
First authorization
25/02/1997
Authorization expiration date
31/12/9999
IT Number
01.07.1.
Domain
Human medicine
Field of application
Antiepileptikum

Package details

Description (FR)
TALOXA susp 600mg/5ml 230 ml
Description (DE)
TALOXA Susp 600mg/5ml 230 ml
Market launch
25/02/1997
Narcotic (BTM)
No
Buy us a coffee Explore the data